首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Control of NF‐kB activity in human melanoma by bromodomain and extra‐terminal protein inhibitor I‐BET151
Authors:Dilini Gunatilake  Kavitha Gowrishankar  Jessamy Tiffen  Wilmott James  Lei Jin  Gulietta Pupo  Carleen Cullinane  Grant A McArthur  Peter J Tummino  Helen Rizos  Peter Hersey
Institution:1. Melanoma Research Group, Kolling Institute of Medical Research, University of Sydney, , St Leonards, NSW, Australia;2. Melanoma Institute of Australia, , North Sydney, NSW, Australia;3. Melanoma Cell Cycle Research Group, Westmead Millennium Institute, University of Sydney, , Westmead, NSW, Australia;4. Translational Research Laboratory, Peter MacCallum Cancer Centre, , Melbourne, Vic., Australia;5. Oncogenic Signalling and Growth Control Program, Peter MacCallum Cancer Centre, , Melbourne, Vic., Australia;6. Cancer Epigenetics Discovery Performance Unit, GlaxoSmithKline, , Collegeville, PA, USA
Abstract:
Keywords:bromodomain and extra‐terminal  melanoma  NF‐kappaB  cytokine  chemokine  cancer
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号